Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12123948 | chr1:247207155 | C/T | 0 | 176 | 25.67 | 23.83 | 2.93 | KM Plot |
PCPG | rs1212871 | chr13:37647838 | C/T | 0.000355 | 176 | 4.17 | 19.1 | 25.97 | KM Plot |
PCPG | rs12138137 | chr1:56325176 | C/T | 2.41E-7 | 171 | 25.87 | 20.02 | 15.6 | KM Plot |
PCPG | rs12138203 | chr1:240454034 | C/T | 0.000281 | 175 | 23.43 | 27.47 | 22.32 | KM Plot |
PCPG | rs12139893 | chr1:247208406 | G/A | 0 | 176 | 25.67 | 23.83 | 2.93 | KM Plot |
PCPG | rs12155466 | chr7:36157419 | C/G | 0.000452 | 177 | 25.87 | 24.5 | 14.37 | KM Plot |
PCPG | rs12155475 | chr7:36157490 | G/A | 0.000452 | 177 | 25.87 | 24.5 | 14.37 | KM Plot |
PCPG | rs12166741 | chr22:27393381 | C/T | 0.000125 | 178 | 25.47 | 25.77 | 17.8 | KM Plot |
PCPG | rs12174402 | chr6:20415005 | A/G | 5.51E-6 | 178 | 25.17 | 30.73 | 23.43 | KM Plot |
PCPG | rs12220898 | chr10:50576633 | C/T | 3.87E-6 | 178 | 24.53 | 33.13 | 25.17 | KM Plot |
PCPG | rs12227928 | chr12:53505113 | G/A | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs12230528 | chr12:53505127 | A/G | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs12232124 | chr14:74597139 | C/T | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs12232131 | chr14:74550381 | A/T | 0.000185 | 178 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs12232167 | chr14:74552589 | A/G | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |